EEC 2024 | The development of adaptive DBS technology for epilepsy

Michael Hart, FRCS(SN), PhD, University of London & St George’s University Hospitals NHS Foundation Trust, London, UK, discusses advancements in neuromodulation for epilepsy, focusing on the development of adaptive deep brain stimulation (DBS) technologies. Dr Hart mentions the CADET study, a trial in the United Kingdom that aims to investigate the safety, feasibility, and effectiveness of thalamic DBS in treating children with Lennox-Gastaut syndrome. Dr Hart then outlines some other stimulatory approaches that are also in development. This interview took place at the 15th European Epilepsy Congress (EEC) 2024 in Rome, Italy.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.